0001213900-22-039458.txt : 20220714
0001213900-22-039458.hdr.sgml : 20220714
20220714192609
ACCESSION NUMBER: 0001213900-22-039458
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220627
FILED AS OF DATE: 20220714
DATE AS OF CHANGE: 20220714
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Knudsen Jens Erik
CENTRAL INDEX KEY: 0001888257
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41160
FILM NUMBER: 221084017
MAIL ADDRESS:
STREET 1: 210 BROADWAY, STE 201
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Allarity Therapeutics, Inc.
CENTRAL INDEX KEY: 0001860657
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 210 BROADWAY
STREET 2: SUITE 201
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 401-426-4664
MAIL ADDRESS:
STREET 1: 210 BROADWAY
STREET 2: SUITE 201
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
4
1
ownership.xml
X0306
4
2022-06-27
1
0001860657
Allarity Therapeutics, Inc.
ALLR
0001888257
Knudsen Jens Erik
1260 APPALACHIAN ROAD
MAPLE GLEN
PA
19002
0
1
0
0
Former Chief Financial Officer
This "Exit" Form 4 is being voluntarily filed to report solely that the Reporting Person is no longer serving in the role as the Company's Chief Financial Officer effective as of June 27, 2022.
/s/ Jens Erik Knudsen
2022-07-14